AusCann (ASX: AC8)

AusCann (ASX: AC8) aims of producing and providing high quality, economical and clinically validated cannabis medicines to patients. Bringing together leading expertise and operations across all aspects of the medical cannabis value chain, beginning with cultivation and production, through to manufacture and distribution of products and has built a strong team of experts and partners with international connections.

AusCann ASX AC8 API successful pilot study cannabinoid capsule marijuana medical

AusCann reports successful study in ‘game changer’ cannabinoid capsules

AusCann (ASX: AC8) is a step closer to releasing its proprietary cannabinoid capsules to world markets after...
AusCann ASX AC8 medical cannabis footprint Canada Australia

AusCann grows its medical cannabis footprint in Canada and Australia

Not long after completing its second harvest in Chile, pharmaceutical company AusCann Group (ASX: AC8) has made plans to...
AusCann ASX AC8 medical cannabis second harvest Chile

AusCann steps up medical cannabis growing operation in Chile

Medicinal cannabis commerciality continues to bloom in all continents, as South America adds its voice to growing...
Auscann ASX AC8 API Australian Pharmaceutical Industries distribution agreement

AusCann strikes distribution agreement with ASX-listed Australian Pharmaceutical Industries

AusCann Group (ASX: AC8), a leading Australian medicinal cannabis company, has announced a Heads of Agreement (HoA)...
AusCann ASX AC8 plants second cannabis crop Chile DayaCann

AusCann plants second cannabis crop in Chile

AusCann (ASX: AC8) has announced the planting of a second medicinal cannabis crop in Chile, with harvest expected...
AusCann ASX AC8 Chile joint venture cannabis cultivation DayaCann Fundacion Daya

AusCann’s Chilean JV fires up for another year of cannabis cultivation

AusCann Group Holdings (ASX: AC8) has acquired another one-year licence allowing it to cultivate cannabis crops at...